Diphenylhydantoin treatment of glycogen storage diseases.
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005260:Female; D005952:Glucose-6-Phosphatase / Q000032:analysis; D005959:Glucosidases / Q000378:metabolism; D005964:Glucosyltransferases / Q000032:analysis / Q000378:metabolism; D006008:Glycogen Storage Disease / Q000188:drug therapy*; D005953:Glycogen Storage Disease Type I / Q000188:drug therapy; D006529:Hepatomegaly / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D006971:Hypersplenism / Q000188:drug therapy; D007773:Lactates / Q000097:blood; D008099:Liver / Q000201:enzymology / Q000473:pathology; D008111:Liver Function Tests; D008112:Liver Glycogen / Q000378:metabolism; D008297:Male; D010672:Phenytoin / Q000627:therapeutic use*; D011877:Radionuclide Imaging
D007773:Lactates; D008112:Liver Glycogen; D010672:Phenytoin; D005964:Glucosyltransferases; D005952:Glucose-6-Phosphatase; D005959:Glucosidases